|By Marketwired .||
|October 16, 2013 03:00 AM EDT||
YOKNEAM, ISRAEL -- (Marketwired) -- 10/16/13 -- Killer cramps can be a thing of the past for women with conditions such as endometriosis, adhesions and uterine fibroids. Lumenis Ltd., the world's largest medical laser company for surgical, aesthetic and ophthalmic applications, is expanding the company's FiberLase family of CO2 laser fibers into gynecological surgery with the new FiberLase GYN handpiece set. This powerful new solution extends the use of the AcuPulse 40WG and AcuPulse DUO CO2 laser systems, giving gynecological surgeons the precision and durability they need to treat these major women's health problems. Lumenis will be introducing the new GYN handpiece set at the European Society for Gynaecological Endoscopy (ESGE), October 16-19, 2013, Berlin, Germany, at Lumenis booth #10.
"Treating endometriosis lesions on critical intra-abdominal structures such as the bowel, bladder, ureter and major blood vessels is utterly challenging as one needs to avoid perforations, minimize risk of adhesion formation and other potential complications," said Ceana Nezhat, MD, FACOG, FACS, Program Director of Minimally Invasive Surgery at Northside Hospital (Atlanta, Georgia, USA). "Using CO2 laser fibers during laparoscopic procedures enables us to precisely target the desired treatment areas with markedly reduced thermal damage to surrounding tissues; it is the wave of the future in minimally invasive gynecological surgery."
The FiberLase family of CO2 fibers is ideal for gynecological surgery because it provides unparalleled energy transmittance. This durable fiber features a renewable tip, as well as an adjustable, clear aiming beam, bringing CO2 fiber technology directly into the abdominal cavity surgery site.
Endometriosis is a common disorder which may be associated with severe abdominal pain episodes and/or infertility. It is caused by abnormal presence of endometrial-like tissue outside of the uterine cavity.
It occurs in up to 10% of all women worldwide and up to 50% of women presenting with pelvic pain. Approximately 50,000 intra-abdominal excision and ablation procedures of endometriosis are performed annually in the U.S.
"Lumenis is a world leader in fiber-delivered CO2 solutions for smart tissue management," said Elad Benjamin, VP & General Manager of the Surgical Business Unit at Lumenis. "CO2 laser surgery has been shown to be associated with low incidence of post operative pain and recurrent disease as well as low complication rates. The CO2 laser energy delivered by the FiberLase and the new GYN handpieces brings this outstanding precision and safety of the CO2 wavelength to the use of gynecological surgeons worldwide."
The new FiberLase GYN handpiece set consists of two individual handpieces, which can be purchased separately:
- GYN LAP-R is a 340mm handpiece with a curved tip and thicker body, which allows the surgeon to operate using the fiber through a 5mm trocar cannula.
- GYN LAP-S is a 460mm straight handpiece (with a smaller handle) which allows the surgeon to introduce the fiber into the operative field through a suction irrigator.
For more information about Lumenis gynecological surgery solutions, visit www.surgical.lumenis.com/gynecology.
Lumenis is a global leader in the field of minimally-invasive clinical solutions for the Surgical, Ophthalmology and Aesthetic markets, and is a world-renowned expert in developing and commercializing innovative energy-based technologies, including Laser, Intense Pulsed Light (IPL) and Radio-Frequency (RF). For nearly 50 years, Lumenis' ground-breaking products have redefined medical treatments and have set numerous technological and clinical gold-standards. Lumenis has successfully created solutions for previously untreatable conditions, as well as designed advanced technologies that have revolutionized existing treatment methods in each and every one of the verticals we operate in. Our drive for innovation stems from an uncompromising commitment to improving the health and well-being of our patients; addressing new and growing needs of aging populations; and in offering medical professionals cutting-edge solutions that fit seamlessly into the health-economics environment of the 21st century. The world over, we bring Energy to Healthcare.
For more information visit: www.lumenis.com
1. Albee R: chapter in Surgical Management of Endometriosis (by David Redwine), Informa Healthcare; 1 edition (January 26, 2004), ISBN-13: 978-1841842486
2. Bellina JH, Fick AC, Jackson JD. Lasers in gynecology: an historical/developmental overview. Lasers Surg Med.1985;5(1):1-22 http://www.ncbi.nlm.nih.gov/pubmed/3157034
3. McLaughlin DS. Micro-laser myomectomy technique to enhance reproductive potential: a preliminary report. Lasers Surg Med. 1982;2(2):107-27 http://www.ncbi.nlm.nih.gov/pubmed/7176798
4. Donnez J, Squifflet J. Complications, pregnancy and recurrence in a prospective series of 500 patients operated on by the shaving technique for deep rectovaginal endometriotic nodules. Human Reproduction, 2010 Aug;25(8):1949-58. Epub 2010 Jun 13. http://www.ncbi.nlm.nih.gov/pubmed/20547557
5. Meuleman C, D'Hoore A, Van Cleynenbreugel B, Beks N, D'Hooghe T. Outcome after multidisciplinary CO2 laser laparoscopic excision of deep infiltrating colorectal endometriosis; Reproductive BioMed Online, 282-289, Vol.18, No.2, 2009 http://www.ncbi.nlm.nih.gov/pubmed/19192351
6. Nezhat C et al. Laparoscopic Management of Bowel Endometriosis: Predictors of Severe Disease and Recurrence, JSLS (2011)15:431-438.
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2429460
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2429462
For further information:
Lazar Partners Ltd.